Literature DB >> 20354170

Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans.

Roger J M W Rennenberg1, Bernard J van Varik, Leon J Schurgers, Karly Hamulyak, Hugo Ten Cate, Tim Leiner, Cees Vermeer, Peter W de Leeuw, Abraham A Kroon.   

Abstract

Vascular calcification is a marker of increased cardiovascular risk. Vitamin K-dependent matrix Gla protein (MGP) is important in inhibiting calcification. Because MGP activation is vitamin K dependent, we performed a cross-sectional study investigating the relationship between the use of vitamin K antagonists and extracoronary vascular calcification. From the Dutch thrombosis services we selected 19 patients younger than 55 years who had no other cardiovascular risk factors and who had used coumarins for more than 10 years, and compared these to 18 matched healthy controls. MGP was measured, and a plain x-ray of the thighs was taken to assess femoral arterial calcifications. The odds ratio for calcification in patients versus controls was 8.5 (95% confidence interval [CI] 2.01-35.95). Coumarin use and MGP were associated with calcification, even after adjusting for other risk factors. We conclude that long-term use of coumarins is associated with enhanced extracoronary vascular calcification, possibly through the inhibition of MGP carboxylation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20354170     DOI: 10.1182/blood-2010-01-264598

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  41 in total

Review 1.  A four-season molecule: osteocalcin. Updates in its physiological roles.

Authors:  Giovanni Lombardi; Silvia Perego; Livio Luzi; Giuseppe Banfi
Journal:  Endocrine       Date:  2014-08-27       Impact factor: 3.633

Review 2.  New insights into modulation of thrombin formation.

Authors:  Henri M H Spronk; Julian I Borissoff; Hugo ten Cate
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

3.  Calcium scoring in patients with a history of Kawasaki disease.

Authors:  Andrew M Kahn; Matthew J Budoff; Lori B Daniels; Susan Jimenez-Fernandez; Amber S Cox; John B Gordon; Jane C Burns
Journal:  JACC Cardiovasc Imaging       Date:  2012-03

4.  [Calciphylaxis. A less well-known, clinically relevant disease].

Authors:  J D Strehl; V Brandenburg; C Forster; C Willam; A Hartmann; K Amann
Journal:  Pathologe       Date:  2011-05       Impact factor: 1.011

5.  Warfarin accelerates ectopic mineralization in Abcc6(-/-) mice: clinical relevance to pseudoxanthoma elasticum.

Authors:  Qiaoli Li; Haitao Guo; David W Chou; Dominic J Harrington; Leon J Schurgers; Sharon F Terry; Jouni Uitto
Journal:  Am J Pathol       Date:  2013-02-15       Impact factor: 4.307

6.  Stabilization of warfarin-binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition.

Authors:  G Shen; S Li; W Cui; S Liu; Q Liu; Y Yang; M Gross; W Li
Journal:  J Thromb Haemost       Date:  2018-05-20       Impact factor: 5.824

Review 7.  The role of vitamin K in soft-tissue calcification.

Authors:  Elke Theuwissen; Egbert Smit; Cees Vermeer
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

8.  Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein.

Authors:  Kelly E Beazley; Saman Eghtesad; Maria V Nurminskaya
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

Review 9.  Vitamin k dependent proteins and the role of vitamin k2 in the modulation of vascular calcification: a review.

Authors:  Margueritta S El Asmar; Joseph J Naoum; Elias J Arbid
Journal:  Oman Med J       Date:  2014-05

10.  Prevention of mutation, cancer, and other age-associated diseases by optimizing micronutrient intake.

Authors:  Bruce N Ames
Journal:  J Nucleic Acids       Date:  2010-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.